Elite Pharmaceuticals
(OTC) ELTP
Elite Pharmaceuticals Financials at a Glance
Market Cap
$409.48M
Revenue (TTM)
$140.12M
Net Income (TTM)
$43.41M
EPS (TTM)
$0.02
P/E Ratio
17.44
Dividend
$0.00
Beta (Volatility)
0.45 (Low)
Dividend
$0.00
Beta (Volatility)
0.45 (Low)
Price
$0.38
Volume
622,150
Open
$0.40
Price
$0.38
Volume
622,150
Open
$0.40
Previous Close
$0.38
Daily Range
$0.37 - $0.40
52-Week Range
$0.27 - $0.82
Dividend
$0.00
Beta (Volatility)
0.45 (Low)
Price
$0.38
Volume
622,150
Open
$0.40
Previous Close
$0.38
Daily Range
$0.37 - $0.40
52-Week Range
$0.27 - $0.82
ELTP News
ELTP: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Elite Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
68
CEO
Nasrat A. Hakim
Website
www.elitepharma.comHeadquarters
Northvale, NJ 07647, US
ELTP Financials
Key Financial Metrics (TTM)
Gross Margin
51%
Operating Margin
36%
Net Income Margin
31%
Return on Equity
74%
Return on Capital
44%
Return on Assets
34%
Earnings Yield
5.73%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$409.48M
Shares Outstanding
1.08B
Volume
622.15K
Short Interest
0.00%
Avg. Volume
754.32K
Financials (TTM)
Gross Profit
$40.09M
Operating Income
$19.60M
EBITDA
$2.84M
Operating Cash Flow
$7.46M
Capital Expenditure
$2.53M
Free Cash Flow
$4.93M
Cash & ST Invst.
$11.32M
Total Debt
$10.91M
Elite Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$31.59M
+119.9%
Gross Profit
$12.95M
+111.7%
Gross Margin
41.01%
N/A
Market Cap
$409.48M
N/A
Market Cap/Employee
$6.40M
N/A
Employees
64
N/A
Net Income
$18.59M
+270.7%
EBITDA
$9.52M
+194.4%
Quarterly Fundamentals
Net Cash
$13.88M
+581.2%
Accounts Receivable
$48.53M
+163.0%
Inventory
$25.10M
+24.5%
Long Term Debt
$6.10M
+0.7%
Short Term Debt
$1.12M
-78.2%
Return on Assets
34.34%
N/A
Return on Invested Capital
44.23%
N/A
Free Cash Flow
$5.48M
-415.6%
Operating Cash Flow
$5.28M
-396.2%